Datasets:

moneuron
/

aur-umb-dataset

Dataset card Viewer Files Files and versions Community

Split (1)

train · 796 rows

ID int64 6 67	author stringclasses 23 values	year int64 2.01k 2.02k	cancerType stringclasses 13 values	cellLine stringclasses 27 values	time int64 8 144	coumarin stringclasses 2 values	coumarinDose float64 0.1 335	viability float64 3.66 109	viabilitySD float64 0.5 24.6	viabilityN int64 2 6	control float64 77.3 111	controlSD float64 0.86 12.5	controlN int64 2 6
6	Movaffagh et al.	2,021	Gastric	MKN-45	24	Auraptene	16.7	93.61	6.39	3	85.81	2.13	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	24	Auraptene	33.4	85.81	2.13	3	85.81	2.13	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	24	Auraptene	66.8	78.95	8.04	3	85.81	2.13	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	24	Auraptene	133.6	52	11.35	3	85.81	2.13	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	48	Auraptene	16.7	92.67	4.49	3	96.69	3.31	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	48	Auraptene	33.4	79.9	5.2	3	96.69	3.31	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	48	Auraptene	66.8	53.19	4.49	3	96.69	3.31	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	48	Auraptene	133.6	37.58	5.91	3	96.69	3.31	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	72	Auraptene	16.7	97.87	1.42	3	92.9	2.84	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	72	Auraptene	33.4	91.48	6.62	3	92.9	2.84	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	72	Auraptene	66.8	60.04	14.19	3	92.9	2.84	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	72	Auraptene	133.6	44.2	5.44	3	92.9	2.84	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	96	Auraptene	16.7	84.86	5.21	3	90.7	2.12	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	96	Auraptene	33.4	69.97	4.26	3	90.7	2.12	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	96	Auraptene	66.8	65.01	6.43	3	90.7	2.12	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	96	Auraptene	133.6	43.26	3.54	3	90.7	2.12	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	120	Auraptene	16.7	74.94	11.34	3	92.9	7.1	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	120	Auraptene	33.4	72.1	10.16	3	92.9	7.1	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	120	Auraptene	66.8	69.97	6.43	3	92.9	7.1	3
6	Movaffagh et al.	2,021	Gastric	MKN-45	120	Auraptene	133.6	41.13	5.67	3	92.9	7.1	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	31.49	50	5.83	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	47.93	50	5.83	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	3.13	88.38	6.36	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	6.25	82.32	2.38	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	12.5	71.21	5.57	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	25	55.34	6.1	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	50	41.59	3.44	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Ovarian	A2780	24	Auraptene	100	22.53	0.79	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	3.13	88.35	11.65	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	6.25	85.44	7.41	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	12.5	72.25	19.84	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	25	69.04	5.03	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	50	64.28	9.26	3	100	3.36	3
8	Jamialahmadi et al.	2,018	Cervical	Hela	24	Auraptene	100	18.78	3.45	3	100	3.36	3
42	Abolhassani et al.	2,023	Prostate	PC3	48	Auraptene	5	93.33	8.23	3	95.68	3.13	3
42	Abolhassani et al.	2,023	Prostate	PC3	48	Auraptene	10	94.5	4.7	3	95.68	3.13	3
42	Abolhassani et al.	2,023	Prostate	PC3	48	Auraptene	20	92.15	6.66	3	95.68	3.13	3
42	Abolhassani et al.	2,023	Prostate	PC3	48	Auraptene	40	85.88	4.7	3	95.68	3.13	3
42	Abolhassani et al.	2,023	Prostate	PC3	48	Auraptene	80	65.88	6.27	3	95.68	3.13	3
42	Abolhassani et al.	2,023	Prostate	PC3	72	Auraptene	5	93.72	3.92	3	88.23	8.62	3
42	Abolhassani et al.	2,023	Prostate	PC3	72	Auraptene	10	85.88	7.84	3	88.23	8.62	3
42	Abolhassani et al.	2,023	Prostate	PC3	72	Auraptene	20	83.13	7.05	3	88.23	8.62	3
42	Abolhassani et al.	2,023	Prostate	PC3	72	Auraptene	40	76.86	10.19	3	88.23	8.62	3
42	Abolhassani et al.	2,023	Prostate	PC3	72	Auraptene	80	64.31	8.23	3	88.23	8.62	3
42	Abolhassani et al.	2,023	Prostate	PC3	96	Auraptene	5	92.94	7.84	3	81.56	8.23	3
42	Abolhassani et al.	2,023	Prostate	PC3	96	Auraptene	10	85.49	10.19	3	81.56	8.23	3
42	Abolhassani et al.	2,023	Prostate	PC3	96	Auraptene	20	81.56	3.13	3	81.56	8.23	3
42	Abolhassani et al.	2,023	Prostate	PC3	96	Auraptene	40	78.43	6.27	3	81.56	8.23	3
42	Abolhassani et al.	2,023	Prostate	PC3	96	Auraptene	80	49.41	1.96	3	81.56	8.23	3
42	Abolhassani et al.	2,023	Prostate	PC3	120	Auraptene	5	86.66	3.92	3	80.78	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	120	Auraptene	10	81.17	8.62	3	80.78	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	120	Auraptene	20	77.64	3.13	3	80.78	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	120	Auraptene	40	73.72	5.88	3	80.78	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	120	Auraptene	80	42.35	4.31	3	80.78	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	144	Auraptene	5	79.6	4.7	3	77.25	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	144	Auraptene	10	76.47	8.23	3	77.25	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	144	Auraptene	20	73.72	3.13	3	77.25	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	144	Auraptene	40	70.58	5.09	3	77.25	6.66	3
42	Abolhassani et al.	2,023	Prostate	PC3	144	Auraptene	80	34.9	5.88	3	77.25	6.66	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	24	Auraptene	16.7	99.25	4.32	3	99.38	3.11	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	24	Auraptene	33.5	100.37	2.47	3	99.38	3.11	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	24	Auraptene	67	99.04	3.7	3	99.38	3.11	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	24	Auraptene	134	97.71	3.09	3	99.38	3.11	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	48	Auraptene	16.7	103.91	2.47	3	103.43	2.47	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	48	Auraptene	33.5	96.98	3.09	3	103.43	2.47	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	48	Auraptene	67	84.53	3.7	3	103.43	2.47	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	48	Auraptene	134	76.37	4.34	3	103.43	2.47	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	72	Auraptene	16.7	105.6	9.87	3	110.65	8	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	72	Auraptene	33.5	102.49	10.49	3	110.65	8	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	72	Auraptene	67	87.02	4.32	3	110.65	8	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	72	Auraptene	134	75.27	8.02	3	110.65	8	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	96	Auraptene	16.7	80.24	7.95	3	82.62	6.41	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	96	Auraptene	33.5	78.18	6.43	3	82.62	6.41	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	96	Auraptene	67	62.05	4.28	3	82.62	6.41	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	96	Auraptene	134	45.63	6.42	3	82.62	6.41	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	120	Auraptene	16.7	91.8	3.67	3	91.46	3.06	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	120	Auraptene	33.5	82.35	1.83	3	91.46	3.06	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	120	Auraptene	67	60.04	9.48	3	91.46	3.06	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	120	Auraptene	134	47.54	6.12	3	91.46	3.06	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	144	Auraptene	16.7	88.86	1.83	3	88.2	3.67	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	144	Auraptene	33.5	78.25	6.41	3	88.2	3.67	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	144	Auraptene	67	56.34	7.95	3	88.2	3.67	3
44	Bagheri et al.	2,022	Leukemia/Lymphoma	MT-2	144	Auraptene	134	40.24	1.83	3	88.2	3.67	3
46	Afshari et al.	2,019	Glioblastoma	U87	8	Auraptene	167.6	70.16	2.76	3	100	1.65	3
46	Afshari et al.	2,019	Glioblastoma	U87	8	Auraptene	335.2	51.93	3.31	3	100	1.65	3
46	Afshari et al.	2,019	Glioblastoma	U87	24	Auraptene	167.6	57.91	3.34	3	100	2.09	3
46	Afshari et al.	2,019	Glioblastoma	U87	24	Auraptene	335.2	42.5	2.91	3	100	2.09	3
47	Epifano et al.	2,013	Colon	HT-29	72	Auraptene	2.5	90.94	4.53	3	99.62	12.45	3
47	Epifano et al.	2,013	Colon	HT-29	72	Auraptene	5	86.41	4.53	3	99.62	12.45	3
47	Epifano et al.	2,013	Colon	HT-29	72	Auraptene	10	75.09	7.55	3	99.62	12.45	3
47	Epifano et al.	2,013	Colon	HT-29	72	Auraptene	20	55.09	16.6	3	99.62	12.45	3
47	Epifano et al.	2,013	Colon	HT-29	72	Auraptene	40	28.3	2.26	3	99.62	12.45	3
47	Epifano et al.	2,013	Colon	HT-116	72	Auraptene	2.5	86.41	9.43	3	100	9.05	3
47	Epifano et al.	2,013	Colon	HT-116	72	Auraptene	5	84.9	19.62	3	100	9.05	3
47	Epifano et al.	2,013	Colon	HT-116	72	Auraptene	10	70.18	19.63	3	100	9.05	3
47	Epifano et al.	2,013	Colon	HT-116	72	Auraptene	20	56.6	3.77	3	100	9.05	3
47	Epifano et al.	2,013	Colon	HT-116	72	Auraptene	40	45.66	17.35	3	100	9.05	3
48	Moon et al.	2,015	Gastric	AGS	48	Auraptene	12.5	92.84	13.58	3	100	2.91	3
48	Moon et al.	2,015	Gastric	AGS	48	Auraptene	25	80.73	9.91	3	100	2.91	3
48	Moon et al.	2,015	Gastric	AGS	48	Auraptene	50	48.44	6.23	3	100	2.91	3